News

In response to the allergy problems of the French, Atmo France and the AASQA have set up the pollen index. The retransmission of this data allows people with allergies to anticipate periods that ...
The Drug Allergy History Tool reliably captured more drug reaction signs and symptoms than documentation included in electronic medical records. The Drug Allergy History Tool, an instrument that ...
Maxwell Whitehorn, more popularly known as Sulfa Ge, had plans to become a recording artiste. But those plans were put aside after he decided that music production was where he had the passion.
HAPPENING TODAY, A SACRAMENTO NINE-YEAR-OLD AND HER THIRD GRADE CLASS WILL SHOW UP TO THE STATE CAPITOL TO PUSH FOR NEW FOOD ALLERGY SAFETY PROTECTIONS IN RESTAURANTS. BUT THAT PROPOSAL IS NOW ...
Undercover Trading Standards officers carried out investigations on a number of businesses across the county, amid concerns many are not doing enough to protect diners who suffer from allergies.
Undercover Trading Standards officers carried out investigations on a number of businesses across the county, amid concerns many are not doing enough to protect diners who suffer from allergies. They ...
But is it just seasonal allergies acting up, or could it be a more concerning sinus infection? With over 100 million Americans suffering from allergies annually and another 29 million battling ...
A scrap­py team of drug de­vel­op­ers has come to­geth­er to cre­ate new med­i­cines for pa­tients with au­toim­mune dis­eases and al­ler­gies. They’re go­ing af­ter the ...
- Series A financing co-led by Bain Capital Life Sciences, BVF Partners and Third Rock Ventures CAMBRIDGE, Mass., April 08, 2025--(BUSINESS WIRE)--Merida Biosciences, a biotechnology company ...
PHOENIX — As the temperature warms up across the state, the Valley is also entering peak allergy season. “This season so far seems to be particularly bad," Dr. Frank LoVecchio, a Valleywise ...
--(BUSINESS WIRE)--Merida Biosciences, a biotechnology company pioneering a new class of precision therapeutics designed to selectively and durably eliminate the pathogenic antibody drivers of ...